Availability of Draft Toxicological Profiles, 66978-66979 [E9-29345]
Download as PDF
<![CDATA[
66978
Federal Register / Vol. 74, No. 241 / Thursday, December 17, 2009 / Notices
such as observation of facial expressions
and listening to verbal feedback. This
package provides a list of generic tasks
and questions for the surveys that can
be used to develop a survey for a
specific CDC Web site, social media,
mobile-based or other electronic
communication channel hosting CDC
content. Screening questions (comprised
of demographic, introductory, or core
questions) are also included in the
package, and a subset of these screening
questions will be used to create the
proper sample for each usability survey.
Participants in a usability survey are
content on a regular, ongoing basis
ensures that users have an effective,
efficient, and satisfying experience on
any of our Web sites or communication
channels, maximizing the health impact
of the information and resulting in
optimum benefit for public health. The
surveys will ensure that all CDC Web
sites and electronic communication
channels meet customer and partner
priorities, build CDC’s brand, and
contribute to CDC health impact goals.
There are no costs to respondents other
than their time.
reflective of the target audience for a
CDC Web site, social media, mobilebased or other electronic
communication channel hosting CDC
content.
Generic clearance is needed to ensure
that CDC can continuously improve its
Web sites, social media, mobile-based or
other electronic communication
channels hosting CDC content through
regular surveys developed from these
pre-defined questions.
Surveying the CDC Web site, social
media, mobile-based or other electronic
communication channels hosting CDC
ESTIMATED ANNUALIZED BURDEN HOURS
Frequency of
response per
respondent
Number of
respondents
Survey type
Average
burden per
response
(hrs.)
Total burden
hours
In Person Surveys ...........................................................................................
Remote Surveys ..............................................................................................
8,000
67,000
1
1
1
30/60
8,000
33,500
Total ..........................................................................................................
75,000
........................
........................
41,500
Dated: December 9, 2009.
Maryam I. Daneshvar,
Acting Reports Clearance Officer, Centers for
Disease Control and Prevention.
[FR Doc. E9–29966 Filed 12–16–09; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Agency for Toxic Substances and
Disease Registry
[ATSDR–256]
Availability of Draft Toxicological
Profiles
wwoods2 on DSK1DXX6B1PROD with NOTICES_PART 1
AGENCY: Agency for Toxic Substances
and Disease Registry (ATSDR),
Department of Health and Human
Services (HHS).
ACTION: Notice of availability.
SUMMARY: The Comprehensive
Environmental Response,
Compensation, and Liability Act of 1980
(CERCLA), as amended by the
Superfund Amendments and
Reauthorization Act of 1986 (SARA),
§ 104(i)(3) [42 U.S.C. 9604(i)(3)], directs
the ATSDR Administrator to prepare
toxicological profiles of priority
hazardous substances and, as necessary,
to revise and publish each updated
toxicological profile. This notice
announces the availability of the 23rd
set of toxicological profiles, which
consists of three new and two updated
drafts prepared by ATSDR for review
and comment.
VerDate Nov<24>2008
13:19 Dec 16, 2009
Jkt 220001
DATES: To be considered, comments on
these draft toxicological profiles must be
received on or before February 26, 2010.
Comments received after the public
comment period will be considered at
the discretion of ATSDR, based on what
it deems in the best interest of the
general public.
ADDRESSES: Send requests for printed
copies of the draft toxicological profiles
to the attention of Ms. Olga Dawkins,
ODawkins@cdc.gov, Division of
Toxicology and Environmental
Medicine, Agency for Toxic Substances
and Disease Registry, Mailstop F–62,
1600 Clifton Road, NE., Atlanta, Georgia
30333. Electronic access to these
documents is also available at the
ATSDR Web site: https://
www.atsdr.cdc.gov/toxpro2.html.
Requests for printed copies of the
draft toxicological profiles must be in
writing and must specifically identify
the hazardous substance(s) profile(s)
you wish to receive. ATSDR reserves the
right to provide free of charge only one
copy of each requested profile.
Requestors will be notified in the event
of extended distribution delays.
Written comments and other data
submitted in response to this notice and
in response to the draft toxicological
profiles should bear the docket control
number ATSDR–256. Send one copy of
all comments and three copies of all
supporting documents to the attention
of Ms. Nickolette Roney, Division of
Toxicology and Environmental
Medicine, Agency for Toxic Substances
and Disease Registry, Mailstop F–62,
PO 00000
Frm 00028
Fmt 4703
Sfmt 4703
1600 Clifton Road, NE., Atlanta, Georgia
30333, no later than the end of the
comment period. Electronic comments
may be sent via e-mail to
TPPublicComments@cdc.gov and
should contain the docket control
number ATSDR–256 in the subject line.
Because all public comments
regarding ATSDR toxicological profiles
are available for public inspection, do
not submit confidential information in
response to this notice.
FOR FURTHER INFORMATION CONTACT: Ms.
Olga Dawkins, Division of Toxicology
and Environmental Medicine, Agency
for Toxic Substances and Disease
Registry, Mailstop F–62, 1600 Clifton
Road, NE., Atlanta, Georgia 30333;
telephone number (800) 232–4636 or
(770) 488–3315.
SUPPLEMENTARY INFORMATION: The
Superfund Amendments and
Reauthorization Act (SARA) (Pub. L.
99–499) amends the Comprehensive
Environmental Response,
Compensation, and Liability Act
(CERCLA or Superfund) (42 U.S.C. 9601
et seq.) by establishing certain
responsibilities for ATSDR and the U.S.
Environmental Protection Agency (U.S.
EPA) with regard to hazardous
substances most commonly found at
facilities on the CERCLA National
Priorities List (NPL). As part of these
responsibilities, the ATSDR
Administrator must prepare
toxicological profiles for substances
enumerated on the priority list of
hazardous substances. This list
identifies 275 hazardous substances
E:\FR\FM\17DEN1.SGM
17DEN1
wwoods2 on DSK1DXX6B1PROD with NOTICES_PART 1
Federal Register / Vol. 74, No. 241 / Thursday, December 17, 2009 / Notices
which, according to ATSDR and U.S.
EPA, pose the most significant potential
threat to human health. The availability
of the revised priority list of 275
hazardous substances was announced in
the Federal Register on March 6, 2008
(73 FR 12178). In addition, ATSDR has
the authority to prepare toxicological
profiles for substances not found at sites
on the National Priorities List, in an
effort to ‘‘* * * establish and maintain
inventory of literature, research, and
studies on the health effects of toxic
substances’’ under CERCLA Section
104(i)(1)(B), to respond to requests for
consultation under section 104(i)(4),
and as otherwise necessary to support
the site-specific response actions
conducted by ATSDR.
For previous versions of the list of
substances, see Federal Register notices
dated April 17, 1987 (52 FR 12866);
October 20, 1988 (53 FR 41280); October
26, 1989 (54 FR 43619); October 17,
1990 (55 FR 42067); October 17, 1991
(56 FR 52166); October 28, 1992 (57 FR
48801); February 28, 1994 (59 FR 9486);
April 29, 1996 (61 FR 18744); November
17, 1997 (62 FR 61332); October 21,
1999 (64 FR 56792); October 25, 2001
(66 FR 54014); November 7, 2003 (68 FR
63098); and December 7, 2005 (70 FR
72840). [CERCLA also requires that
ATSDR initiate a research program to
fill data needs associated with the
substances.] Section 104(i)(3) of
CERCLA [42 U.S.C. 9604(i)(3)] outlines
the content of these profiles. Each
profile will include an examination, a
summary, and an interpretation of
available toxicological information and
epidemiological evaluations. This
information and these data identify the
levels of significant human exposure for
the substance and for the associated
health effects. The profiles must also
include a determination of whether
adequate information on the health
effects of each substance is available or
is in the process of development. If
adequate information is not available,
ATSDR, in cooperation with the
National Toxicology Program (NTP), is
required to ensure the initiation of
research to determine such health
effects.
Although during the profile
development process ATSDR
considered key studies for each of the
substances, this Federal Register notice
solicits any relevant, additional studies,
particularly unpublished data and
ongoing studies. ATSDR will evaluate
such data or studies for possible
addition to the profiles, now or in the
future.
The following draft toxicological
profiles have been made available to the
public:
VerDate Nov<24>2008
13:19 Dec 16, 2009
Jkt 220001
Toxicological profile
1.
2.
3.
4.
CAS Number
Acrylamide ........................
Carbon Monoxide .............
1,3–Butadiene ..................
Phosphate Ester Flame
Retardants .........................
5. Vanadium .........................
79–06–1
630–08–0
106–99–0
78–51–3
126–73–8
126–71–6
115–86–6
13674–84–5
13674–87–8
115–96–8
7440–62–2
All profiles issued as ‘‘Drafts for
Public Comment’’ represent ATSDR’s
best efforts to provide important
toxicological information on priority
hazardous substances. We seek public
comment and additional information
that may supplement these profiles.
ATSDR remains committed to providing
a public comment period for these
documents as the best means to serve
public health and our clients.
Dated: December 4, 2009.
Ken Rose,
Director, Office of Policy, Planning and
Evaluation, National Center for
Environmental Health/Agency for Toxic
Substances and Disease Registry.
[FR Doc. E9–29345 Filed 12–16–09; 8:45 am]
66979
117 N. Welcome Slough Rd., Puget
Island, Cathlamet, WA 98612. The
petition proposes to amend the food
additive regulations in part 172 Food
Additives Permitted for Direct Addition
to Food for Human Consumption (21
CFR part 172) to provide for the safe use
of vitamin D2 bakers yeast as a dual
purpose nutrient supplement and
leavening agent or dough relaxer in
yeast-containing baked products.
The agency has determined under 21
CFR 25.32(k) that this action is of a type
that does not individually or
cumulatively have a significant effect on
the human environment. Therefore,
neither an environmental assessment
nor an environmental impact statement
is required.
Dated: December 8, 2009.
Laura M. Tarantino,
Director, Office of Food Additive Safety,
Center for Food Safety and Applied Nutrition.
[FR Doc. E9–29961 Filed 12–16–09; 8:45 am]
BILLING CODE 4160–01–S
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Health Resources and Services
Administration
BILLING CODE 4163–70–P
Health Center Program
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2009–F–0570]
Lallemand, Inc.; Filing of Food Additive
Petition
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
SUMMARY: The Food and Drug
Administration (FDA) is announcing
that Lallemand, Inc., has filed a petition
proposing that the food additive
regulations be amended to provide for
the safe use of vitamin D2 bakers yeast
as a dual purpose nutrient supplement
and leavening agent or dough relaxer in
yeast-containing baked products.
FOR FURTHER INFORMATION CONTACT:
Judith Kidwell, Center for Food Safety
and Applied Nutrition (HFS–265), Food
and Drug Administration, 5100 Paint
Branch Pkwy., College Park, MD 20740–
3835, 301–436–1071.
SUPPLEMENTARY INFORMATION: Under the
Federal Food, Drug, and Cosmetic Act
(sec. 409(b)(5) (21 U.S.C. 348(b)(5))),
notice is given that a food additive
petition (FAP 9A4779) has been filed by
Lallemand, Inc., c/o Dennis T. Gordon,
PO 00000
Frm 00029
Fmt 4703
Sfmt 4703
AGENCY: Health Resources and Services
Administration, HHS.
ACTION: Notice of noncompetitive
replacement awards to Regional Health
Care Affiliates.
SUMMARY: The Health Resources and
Services Administration (HRSA) will be
transferring Health Center Program
(section 330 of the Public Health Service
Act) New Access Point (NAP) and
Increased Demand for Service (IDS)
funds originally awarded to Trover
Health System to Regional Health Care
Affiliates to ensure the provision of
critical primary health care services to
underserved populations in Webster
and McLean Counties, Kentucky.
SUPPLEMENTARY INFORMATION:
Former Grantee of Record: Trover
Health System.
Original Period of Grant Support:
March 1, 2009 to February 28, 2011
(NAP) and March 27, 2009 to March 26,
2011 (IDS).
Replacement Awardee: Regional
Health Care Affiliates.
Amount of Replacement Awards:
$1,300,000 (NAP) and $101,000 (IDS).
Period of Replacement Awards: The
period of support for the replacement
awards is March 1, 2009, to February 28,
2011 (NAP) and March 27, 2009, to
March 26, 2009 (IDS).
E:\FR\FM\17DEN1.SGM
17DEN1
]]>Agencies
[Federal Register Volume 74, Number 241 (Thursday, December 17, 2009)]
[Notices]
[Pages 66978-66979]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-29345]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Agency for Toxic Substances and Disease Registry
[ATSDR-256]
Availability of Draft Toxicological Profiles
AGENCY: Agency for Toxic Substances and Disease Registry (ATSDR),
Department of Health and Human Services (HHS).
ACTION: Notice of availability.
-----------------------------------------------------------------------
SUMMARY: The Comprehensive Environmental Response, Compensation, and
Liability Act of 1980 (CERCLA), as amended by the Superfund Amendments
and Reauthorization Act of 1986 (SARA), Sec. 104(i)(3) [42 U.S.C.
9604(i)(3)], directs the ATSDR Administrator to prepare toxicological
profiles of priority hazardous substances and, as necessary, to revise
and publish each updated toxicological profile. This notice announces
the availability of the 23rd set of toxicological profiles, which
consists of three new and two updated drafts prepared by ATSDR for
review and comment.
DATES: To be considered, comments on these draft toxicological profiles
must be received on or before February 26, 2010. Comments received
after the public comment period will be considered at the discretion of
ATSDR, based on what it deems in the best interest of the general
public.
ADDRESSES: Send requests for printed copies of the draft toxicological
profiles to the attention of Ms. Olga Dawkins, ODawkins@cdc.gov,
Division of Toxicology and Environmental Medicine, Agency for Toxic
Substances and Disease Registry, Mailstop F-62, 1600 Clifton Road, NE.,
Atlanta, Georgia 30333. Electronic access to these documents is also
available at the ATSDR Web site: https://www.atsdr.cdc.gov/toxpro2.html.
Requests for printed copies of the draft toxicological profiles
must be in writing and must specifically identify the hazardous
substance(s) profile(s) you wish to receive. ATSDR reserves the right
to provide free of charge only one copy of each requested profile.
Requestors will be notified in the event of extended distribution
delays.
Written comments and other data submitted in response to this
notice and in response to the draft toxicological profiles should bear
the docket control number ATSDR-256. Send one copy of all comments and
three copies of all supporting documents to the attention of Ms.
Nickolette Roney, Division of Toxicology and Environmental Medicine,
Agency for Toxic Substances and Disease Registry, Mailstop F-62, 1600
Clifton Road, NE., Atlanta, Georgia 30333, no later than the end of the
comment period. Electronic comments may be sent via e-mail to
TPPublicComments@cdc.gov and should contain the docket control number
ATSDR-256 in the subject line.
Because all public comments regarding ATSDR toxicological profiles
are available for public inspection, do not submit confidential
information in response to this notice.
FOR FURTHER INFORMATION CONTACT: Ms. Olga Dawkins, Division of
Toxicology and Environmental Medicine, Agency for Toxic Substances and
Disease Registry, Mailstop F-62, 1600 Clifton Road, NE., Atlanta,
Georgia 30333; telephone number (800) 232-4636 or (770) 488-3315.
SUPPLEMENTARY INFORMATION: The Superfund Amendments and Reauthorization
Act (SARA) (Pub. L. 99-499) amends the Comprehensive Environmental
Response, Compensation, and Liability Act (CERCLA or Superfund) (42
U.S.C. 9601 et seq.) by establishing certain responsibilities for ATSDR
and the U.S. Environmental Protection Agency (U.S. EPA) with regard to
hazardous substances most commonly found at facilities on the CERCLA
National Priorities List (NPL). As part of these responsibilities, the
ATSDR Administrator must prepare toxicological profiles for substances
enumerated on the priority list of hazardous substances. This list
identifies 275 hazardous substances
[[Page 66979]]
which, according to ATSDR and U.S. EPA, pose the most significant
potential threat to human health. The availability of the revised
priority list of 275 hazardous substances was announced in the Federal
Register on March 6, 2008 (73 FR 12178). In addition, ATSDR has the
authority to prepare toxicological profiles for substances not found at
sites on the National Priorities List, in an effort to ``* * *
establish and maintain inventory of literature, research, and studies
on the health effects of toxic substances'' under CERCLA Section
104(i)(1)(B), to respond to requests for consultation under section
104(i)(4), and as otherwise necessary to support the site-specific
response actions conducted by ATSDR.
For previous versions of the list of substances, see Federal
Register notices dated April 17, 1987 (52 FR 12866); October 20, 1988
(53 FR 41280); October 26, 1989 (54 FR 43619); October 17, 1990 (55 FR
42067); October 17, 1991 (56 FR 52166); October 28, 1992 (57 FR 48801);
February 28, 1994 (59 FR 9486); April 29, 1996 (61 FR 18744); November
17, 1997 (62 FR 61332); October 21, 1999 (64 FR 56792); October 25,
2001 (66 FR 54014); November 7, 2003 (68 FR 63098); and December 7,
2005 (70 FR 72840). [CERCLA also requires that ATSDR initiate a
research program to fill data needs associated with the substances.]
Section 104(i)(3) of CERCLA [42 U.S.C. 9604(i)(3)] outlines the content
of these profiles. Each profile will include an examination, a summary,
and an interpretation of available toxicological information and
epidemiological evaluations. This information and these data identify
the levels of significant human exposure for the substance and for the
associated health effects. The profiles must also include a
determination of whether adequate information on the health effects of
each substance is available or is in the process of development. If
adequate information is not available, ATSDR, in cooperation with the
National Toxicology Program (NTP), is required to ensure the initiation
of research to determine such health effects.
Although during the profile development process ATSDR considered
key studies for each of the substances, this Federal Register notice
solicits any relevant, additional studies, particularly unpublished
data and ongoing studies. ATSDR will evaluate such data or studies for
possible addition to the profiles, now or in the future.
The following draft toxicological profiles have been made available
to the public:
------------------------------------------------------------------------
Toxicological profile CAS Number
------------------------------------------------------------------------
1. Acrylamide........................................... 79-06-1
2. Carbon Monoxide...................................... 630-08-0
3. 1,3-Butadiene........................................ 106-99-0
4. Phosphate Ester Flame Retardants..................... 78-51-3
126-73-8
126-71-6
115-86-6
13674-84-5
13674-87-8
115-96-8
5. Vanadium............................................. 7440-62-2
------------------------------------------------------------------------
All profiles issued as ``Drafts for Public Comment'' represent
ATSDR's best efforts to provide important toxicological information on
priority hazardous substances. We seek public comment and additional
information that may supplement these profiles. ATSDR remains committed
to providing a public comment period for these documents as the best
means to serve public health and our clients.
Dated: December 4, 2009.
Ken Rose,
Director, Office of Policy, Planning and Evaluation, National Center
for Environmental Health/Agency for Toxic Substances and Disease
Registry.
[FR Doc. E9-29345 Filed 12-16-09; 8:45 am]
BILLING CODE 4163-70-P
